Author | Jorge J. Castillo, MD | OncLive

Author | Jorge J. Castillo, MD

Articles

Dr. Castillo on the Use of Venetoclax in Waldenstrom Macroglobulinemia

September 15, 2019

Video

Jorge J. Castillo, MD, clinical director, Bing Center for Waldenström Macroglobulinemia, physician, associate professor of medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses the results of a multicenter, prospective, phase II study of venetoclax in patients with previously treated Waldenstrom macroglobulinemia.

Dr. Castillo on Emerging Treatment Approaches in Waldenstrom Macroglobulinemia

August 14, 2019

Video

Jorge J. Castillo, MD, clinical director, Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, and associate professor of medicine, Harvard Medical School, highlights ongoing research with emerging treatment approaches in Waldenström macroglobulinemia.

x